Chinese PLA General Hospital: clinical-trial pipeline
Chinese PLA General Hospital is the sponsor of 568 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 172 are not yet finished and 12 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials172
Phase 2/3 and 316
Countries1
New in 90 days12
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 330 |
| Phase 1/2 | 68 |
| Phase 2 | 66 |
| Phase 1 | 40 |
| Phase 4 | 36 |
| Early phase 1 | 12 |
| Phase 3 | 10 |
| Phase 2/3 | 6 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 255 |
| Completed | 138 |
| Recruiting | 99 |
| Not yet recruiting | 67 |
| Active, not recruiting | 6 |
| Withdrawn or not authorised | 3 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 205 |
| Cardiovascular | 90 |
| Nephrology and urology | 56 |
| Gastroenterology and liver | 52 |
| Infectious disease and vaccines | 40 |
| Neurology | 34 |
| Metabolic and endocrine (diabetes, obesity) | 33 |
| Immunology and rheumatology | 32 |
| Psychiatry and mental health | 19 |
| Rare and genetic diseases | 19 |
| Haematology | 17 |
| Musculoskeletal | 15 |
Countries
| Country | Trials |
|---|---|
| China | 485 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-23 | New trial posted | The Intervention Effect of Exercise on Lumbar Multifidus Muscle Injuries |
| 2026-10-20 | New trial posted | BEX101 in B-cell Non-Hodgkin's Lymphoma |
| 2026-10-16 | New trial posted | Serratus Anterior Plane Block for Recovery After Minimally Invasive CABG |
| 2026-10-05 | New trial posted | Low-Intensity Focused Ultrasound Targeting the Dorsolateral Prefrontal Cortex for Prevent… |
| 2026-09-16 | New trial posted | A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian… |
| 2026-09-15 | New trial posted | Epidemiological Survey on the Current Status of Cochlear Implantation in China |
| 2026-09-14 | New trial posted | Validity of the 3-item Patient Health Questionnaire (PHQ-3) for Identifying Moderate-to-S… |
| 2026-09-14 | New trial posted | Renal Oxygenation-Guided AKI Reduction Trial |
| 2026-09-04 | New trial posted | Prospective Randomized Controlled Study: Amimaitosai Injection Combined With Corticostero… |
| 2026-09-01 | New trial posted | Ultrasound-Guided Emulsification Therapy in the Clinical Treatment of Subcutaneous Lipomas |
| 2026-09-01 | New trial posted | Ultrasound-Guided Emulsification Therapy in the Clinical Treatment of Benign Breast Nodul… |
| 2026-08-28 | New trial posted | Population PK-guided ATG Dosing in Haplo-HSCT |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07620275 | Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA | Phase 1 | Recruiting | China |
| NCT06014073 | TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL | Phase 1/2 | Recruiting | China |
| NCT05839314 | Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy | Phase 4 | Recruiting | China |
| NCT03865914 | Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy | Not applicable | Recruiting | China |
| NCT07882641 | BEX101 in B-cell Non-Hodgkin's Lymphoma | Phase 1/2 | Recruiting | China |
| NCT06729762 | Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules | Not applicable | Recruiting | China |
| NCT05721703 | An Observational Study of Long-term Peritoneal Dialysis Patients Who Eventually Develop Ultrafiltration Failu… | Not applicable | Active, not recruiting | China |
| NCT07525037 | Chinese, Overweight or Obesity, Real-World Registry Study | Not applicable | Not yet recruiting | China |
| NCT07067905 | Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Ce… | Early phase 1 | Recruiting | China |
| NCT07592754 | The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder. | Early phase 1 | Not yet recruiting | China |
| NCT06713031 | Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures | Not applicable | Not yet recruiting | China |
| NCT05715138 | Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia | Not applicable | Not yet recruiting | China |
| NCT06733766 | Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer | Not applicable | Recruiting | China |
| NCT06939270 | CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors | Phase 1/2 | Not yet recruiting | China |
| NCT06713291 | Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femoral Neck Fractures | Not applicable | Recruiting | China |
| NCT05554939 | Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL | Phase 1/2 | Recruiting | China |
| NCT07127185 | Individualized Precision Therapy With Ceftobiprole Guided by PK/PD in Geriatric Populations | Not applicable | Recruiting | China |
| NCT06481735 | TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL | Phase 1/2 | Recruiting | China |
| NCT06170086 | Early Neurological Trajectory and Clinical Outcomes in Brain Acute Ischemic Stroke | Not applicable | Active, not recruiting | China |
| NCT07063108 | Efficacy and Safety of S-ketamine in Elderly Patients Undergoing Non-cardiac Surgery: a RCT（ESSENCE） | Phase 4 | Not yet recruiting | |
| NCT06838832 | Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL | Phase 1/2 | Recruiting | China |
| NCT05453019 | Effects of CI on Tinnitus and Its Symptoms | Not applicable | Recruiting | China |
| NCT07072858 | Using Cardiac MRI to Predict Outcomes in Patients With STEMI | Not applicable | Recruiting | China |
| NCT06681155 | Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging | Not applicable | Not yet recruiting | China |
| NCT05738525 | Comparative Study of Prognosis and QOL Between APD-RPM and CAPD | Not applicable | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Chinese PLA General Hospital clinical trials: 172 open, 16 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/chinese-pla-general-hospital/, data as of 2026-10-25.